Security Snapshot

Teladoc Health, Inc. - Common Stock (TDOC) Institutional Ownership

CUSIP: 87918A105

13F Institutional Holders and Ownership History from Q2 2015 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

337

Shares (Excl. Options)

132,196,087

Price

$7.00

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
TDOC on NYSE
Shares outstanding
175,611,455
Price per share
$5.45
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
132,196,087
Total reported value
$925,457,583
% of total 13F portfolios
0%
Share change
+7,144,988
Value change
+$47,135,087
Number of holders
337
Price from insider filings
$5.45
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • TDOC - Teladoc Health, Inc. - Common Stock is tracked under CUSIP 87918A105.
  • 337 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 337 to 31 between Q4 2025 and Q1 2026.
  • Reported value moved from $925,457,583 to $11,099,200.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 337 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 87918A105?
CUSIP 87918A105 identifies TDOC - Teladoc Health, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Teladoc Health, Inc. - Common Stock (TDOC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.8% $99,368,053 13,556,351 BlackRock, Inc. 31 Mar 2025
Point72 Asset Management, L.P. 3.3% -34% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025

As of 31 Dec 2025, 337 institutional investors reported holding 132,196,087 shares of Teladoc Health, Inc. - Common Stock (TDOC). This represents 75% of the company’s total 175,611,455 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Teladoc Health, Inc. - Common Stock (TDOC) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 21,483,707 -1.9% 0% $150,385,949
BlackRock, Inc. 8.1% 14,260,269 +2.8% 0% $99,821,883
RENAISSANCE TECHNOLOGIES LLC 4.5% 7,978,142 -2.4% 0.09% $55,846,994
DIMENSIONAL FUND ADVISORS LP 4.3% 7,494,255 +8.8% 0.01% $52,459,425
Point72 Asset Management, L.P. 3.2% 5,661,322 -1.8% 0.06% $39,629,254
STATE STREET CORP 2.4% 4,250,144 -8.8% 0% $29,751,008
GEODE CAPITAL MANAGEMENT, LLC 2.4% 4,188,313 +0.44% 0% $29,323,749
JUPITER ASSET MANAGEMENT LTD 2.2% 3,860,076 +294% 0.22% $27,020,532
Allianz Asset Management GmbH 1.8% 3,115,191 +92% 0.02% $21,806,337
AMERICAN CENTURY COMPANIES INC 1.8% 3,089,316 +509% 0.01% $21,625,212
Nuveen, LLC 1.5% 2,659,662 +39% 0% $18,617,634
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.5% 2,546,622 +0.18% 0% $17,826,351
Monaco Asset Management SAM 1.1% 1,956,947 +159% 4.1% $13,698,629
Pale Fire Capital SE 1.1% 1,944,203 1.8% $13,609,421
GOLDMAN SACHS GROUP INC 1.1% 1,924,533 -24% 0% $13,471,731
NORTHERN TRUST CORP 0.98% 1,727,509 -5% 0% $12,092,563
MORGAN STANLEY 0.95% 1,675,282 -53% 0% $11,726,979
Man Group plc 0.92% 1,620,633 +114% 0.02% $11,344,431
BNP PARIBAS FINANCIAL MARKETS 0.89% 1,557,832 0% 0.01% $10,904,824
AMERIPRISE FINANCIAL INC 0.86% 1,517,171 -34% 0% $10,620,197
MILLENNIUM MANAGEMENT LLC 0.86% 1,510,686 +407% 0.01% $10,574,802
UBS Group AG 0.85% 1,498,551 +25% 0% $10,489,857
TANG CAPITAL MANAGEMENT LLC 0.8% 1,400,000 0% 0.48% $9,800,000
Trexquant Investment LP 0.74% 1,307,952 0.08% $9,155,664
SG Americas Securities, LLC 0.74% 1,297,185 +320% 0.01% $9,080,000

Institutional Holders of Teladoc Health, Inc. - Common Stock (TDOC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,038,785 $11,099,200 +$3,400,616 $5.45 31
2025 Q4 132,196,087 $925,457,583 +$47,135,087 $7.00 337
2025 Q3 123,376,453 $953,989,710 -$44,391,699 $7.73 349
2025 Q2 127,657,050 $1,111,810,150 +$28,908,039 $8.71 348
2025 Q1 124,764,453 $993,137,558 -$13,210,237 $7.96 368
2024 Q4 126,600,183 $1,150,909,215 +$5,732,507 $9.09 366
2024 Q3 125,343,265 $1,150,235,748 -$100,725,771 $9.18 352
2024 Q2 138,653,865 $1,356,107,775 +$78,896,049 $9.78 389
2024 Q1 129,813,184 $1,959,292,768 +$8,558,227 $15.10 411
2023 Q4 128,213,716 $2,762,470,436 +$64,064,682 $21.55 425
2023 Q3 124,707,305 $2,318,095,592 -$112,449,287 $18.59 418
2023 Q2 128,734,634 $3,259,624,540 -$197,804,335 $25.32 418
2023 Q1 136,344,301 $3,528,176,976 +$69,660,076 $25.90 416
2022 Q4 134,795,560 $3,187,915,143 -$88,463,415 $23.65 419
2022 Q3 137,929,338 $3,500,590,930 -$132,587,746 $25.35 421
2022 Q2 142,508,101 $4,752,897,156 -$35,457,280 $33.21 492
2022 Q1 135,294,586 $9,760,150,727 -$44,236,110 $72.13 640
2021 Q4 135,661,577 $12,464,617,010 -$96,730,604 $91.82 689
2021 Q3 133,460,521 $16,925,944,366 +$674,213,489 $126.81 738
2021 Q2 127,751,069 $21,259,926,344 +$1,036,756,412 $166.29 807
2021 Q1 121,322,454 $22,048,095,012 +$973,044,719 $181.75 873
2020 Q4 109,175,126 $21,828,607,477 +$6,575,258,095 $199.96 869
2020 Q3 75,563,046 $16,555,972,646 +$917,790,340 $219.24 730
2020 Q2 71,460,376 $13,644,498,539 -$180,652,715 $190.84 654
2020 Q1 72,838,954 $11,295,952,445 -$2,132,897,022 $155.01 559
2019 Q4 87,035,459 $7,286,337,875 -$311,263,665 $83.72 404
2019 Q3 90,856,564 $6,151,556,774 +$311,350,683 $67.72 365
2019 Q2 86,279,161 $5,708,002,798 +$184,430,573 $66.41 360
2019 Q1 84,967,430 $4,724,239,062 +$201,451,274 $55.60 355
2018 Q4 81,502,841 $4,039,756,305 +$65,534,475 $49.57 321
2018 Q3 78,683,955 $6,793,917,690 +$279,097,203 $86.35 330
2018 Q2 76,024,459 $4,413,324,206 -$62,794,723 $58.05 272
2018 Q1 77,172,756 $3,107,046,518 +$70,245,035 $40.30 229
2017 Q4 75,618,965 $2,635,297,138 +$300,630,734 $34.85 204
2017 Q3 65,338,332 $2,166,327,928 +$268,095,591 $33.15 177
2017 Q2 57,326,616 $1,989,441,272 +$288,789,640 $34.70 165
2017 Q1 50,788,462 $1,269,721,925 +$612,842,037 $25.00 131
2016 Q4 28,818,430 $475,514,658 +$62,340,869 $16.50 107
2016 Q3 24,591,861 $450,136,800 +$92,859,707 $18.31 101
2016 Q2 18,488,436 $296,177,335 +$63,261,690 $16.02 85
2016 Q1 15,770,964 $151,754,000 -$36,741,446 $9.60 78
2015 Q4 18,650,348 $334,951,386 -$60,380,110 $17.96 73
2015 Q3 20,870,768 $457,767,253 +$452,106,452 $22.29 88
2015 Q2 266,265 $5,009,000 +$5,009,000 $19.00 14